CARTEOLOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Carteolol, and what generic alternatives are available?
Carteolol is a drug marketed by Apotex Inc, Bausch And Lomb, and Sandoz. and is included in three NDAs.
The generic ingredient in CARTEOLOL is carteolol hydrochloride. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the carteolol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Carteolol
A generic version of CARTEOLOL was approved as carteolol hydrochloride by SANDOZ on January 3rd, 2000.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CARTEOLOL?
- What are the global sales for CARTEOLOL?
- What is Average Wholesale Price for CARTEOLOL?
Summary for CARTEOLOL
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Drug Prices: | Drug price information for CARTEOLOL |
| DailyMed Link: | CARTEOLOL at DailyMed |
US Patents and Regulatory Information for CARTEOLOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apotex Inc | CARTEOLOL HYDROCHLORIDE | carteolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 076097-001 | Feb 6, 2002 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bausch And Lomb | CARTEOLOL HYDROCHLORIDE | carteolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 075546-001 | Jan 20, 2000 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sandoz | CARTEOLOL HYDROCHLORIDE | carteolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 075476-001 | Jan 3, 2000 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
